Immunization, Hib3 in Kiribati
Kiribati: Immunization, Hib3 was 94.0% in 2024. ▲ Rising
Immunization, Hib3 in Kiribati, 2008–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Kiribati is 94.0%, measured in 2024.
That represents a change of up 4.4% on the previous year and up 25.3% over ten years.
Over the whole period, immunization, hib3 in Kiribati peaked at 97.0% in 2019 and was at its lowest, 75.0%, in 2014.
Kiribati ranks 64th of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 17 years of available data.
Immunization, Hib3 in Kiribati, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2008 | 83.0% | — |
| 2009 | 86.0% | +3.6% |
| 2010 | 91.0% | +5.8% |
| 2011 | 95.0% | +4.4% |
| 2012 | 94.0% | -1.1% |
| 2013 | 95.0% | +1.1% |
| 2014 | 75.0% | -21.1% |
| 2015 | 82.0% | +9.3% |
| 2016 | 81.0% | -1.2% |
| 2017 | 90.0% | +11.1% |
| 2018 | 95.0% | +5.6% |
| 2019 | 97.0% | +2.1% |
| 2020 | 92.0% | -5.2% |
| 2021 | 90.0% | -2.2% |
| 2022 | 91.0% | +1.1% |
| 2023 | 90.0% | -1.1% |
| 2024 | 94.0% | +4.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.5% | 83.0% | 86.0% | 2 |
| 2010s | 89.5% | 75.0% | 97.0% | 10 |
| 2020s | 91.4% | 90.0% | 94.0% | 5 |
Countries ranked near Kiribati
- 64 Armenia 94.0% compare
- 64 Barbados 94.0% compare
- 64 Botswana 94.0% compare
- 64 Bulgaria 94.0% compare
- 64 Cyprus 94.0% compare
- 64 Fiji 94.0% compare
- 64 Iceland 94.0% compare
- 64 India 94.0% compare
- 64 Poland 94.0% compare
- 64 Seychelles 94.0% compare
- 64 Spain 94.0% compare
- 64 Tuvalu 94.0% compare
- 64 Uruguay 94.0% compare
More health data for Kiribati
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7209 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,076 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.3672 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0576 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3464 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Kiribati?
- Immunization, hib3 in Kiribati was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Kiribati?
- The highest recorded value was 97.0% in 2019.
- What is the lowest immunization, hib3 recorded in Kiribati?
- The lowest recorded value was 75.0% in 2014.
- How does Kiribati rank for immunization, hib3?
- Kiribati ranks 64th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Kiribati?
- Over the last ten years it is up 25.3%. The long-run trend across the full record is rising.
- Where does this Kiribati data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.